Parnell Board


    • Dr. Alan Bell - Chairman

    • Dr Alan Bell completed his degree in Veterinary Science in 1979 and after completing his initial appointments in mixed practice and large animal practice in rural New South Wales, Alan quickly moved into Equine practice – his true passion. Alan moved to Sydney to open his own practice in the highly competitive Sydney racing industry.

      In 1986 at the age of 30, Alan purchased Parnell from the retiring owner Dr Richard Boon.  Over the next 20 years Alan continued to work as an Equine Veterinarian as well as becoming a well-known horse breeder, racehorse owner and syndicator and ultimately a championship winning thoroughbred horse trainer in Sydney.

      In 2005 Alan decided he wanted to grow Parnell to be a global player in the veterinary market and ultimately make Parnell an accredited FDA facility which became a reality in 2013. Alan is Chairman of the Board and continues to work closely with both the CEO and CFO.


    • Mr. Robert Joseph – President and Chief Executive Officer

    • Robert joined Dr Alan Bell in 2006 as an equity partner at Parnell assuming the role of President and Chief Executive Officer. Along with Chief Financial Officer Brad McCarthy, Robert has raised over $35 million to develop two of Parnell’s technology platforms in osteoarthritis and cattle reproduction with significant global potential. Robert has a demonstrable track record in finance, strategic marketing, human resource management, scientific and regulatory affairs and legal.

      Robert started his finance career in the manufacturing operations of Australian-based Herron Pharmaceuticals before joining Allergan in their Sydney office as the Financial Planning and Analysis Manager.  Robert then made the switch to commercial operations at Eli Lilly as the Strategic Marketing Manager then moved to the Indianapolis global headquarters where he was part of the Global Diabetes Marketing team responsible for the highly successful launch of Lilly’s insulin products and drug delivery devices. Robert has undergraduate degrees in Medicine, Finance and Marketing and is a qualified CPA.


    • Mr. Brad McCarthy – Chief Financial Officer and Chief Operating Officer of Parnell Manufacturing

    • Brad joined Parnell as CFO in January 2010, and in 2012 assumed the additional role of Chief Operating Officer of Parnell Manufacturing overseeing the successful FDA approval of Parnell’s new manufacturing facility.

      Brad commenced his career as one of the first employees to join Volkswagen Group Australia in the finance team. Brad then moved to London and commenced a six year stint at SIRVA Inc., the largest removals and relocation organisation in the world. As VP of Forecasting Planning and Analysis; Europe, Brad was responsible for 13 European countries with a turnover of $US350m. In 2007, Brad led SIRVA’s divestment of its European operations, running multiple M&A transactions valued at over $US100m. Brad then became CFO of the SIRVA subsidiary Pickfords Removals and led the transition of the finance back-office from London to Kuala Lumpur.

      Brad has an undergraduate degree in Science, majoring in Physiology and Pharmacology before completing degrees in Business Administration and Commerce as well as his CPA.

To
Top